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Abstract
About 8-10% of normal Northern Europeans are heterozygous carriers of common FLG mutations, while only 1-4% of southern
Europeansdisplay thesemutations,andonly very rarelyaremutationsdetected inAfricanpopulations.Althoughmutationsare found
in Asians, they are different from those encountered in Northern Europeans. Importantly, FLGmutation carriers have 10% increased
serum vitamin D concentrations compared to controls. Based on these observations, we have proposed that this latitude-dependent
gradient of FLG mutations across Europe, Asia and Africa could have provided an evolutionary advantage for heterozygous FLG
mutation carriers, residing at northern latitudes, depletion of the FLG downstream product, trans-urocanic acid, would facilitate the
intracutaneous synthesis of vitamin D3 by allowing increased transcutaneous absorption of UVB photons. Such loss-of-function FLG
mutations would have provided an evolutionary advantage for modern humans, living in the far North of Europe, where little UV-B
penetrates the atomosphere. In a recent article, it was concluded not only that the UVB-Vitamin D3 hypothesis is invalid, but also that
FLG genetic variations, including loss-of-function variants, provide little or no impact on the fitness of modern humans. While we
welcome studies that reassess our hypothesis, their conclusions are not valid for reasons explained in this letter.
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The epidermal barrier protects human skin from exogenous
stressors and prevents water loss from the skin surface. One
epidermal protein that has attracted much attention recently
is filaggrin; an intracellular protein that aligns keratin filaments
before its degradation to amino acids that maintain skin hy-
dration, including a deiminated product, trans-urocanic acid
(t-UCA) that provides substantial protection against ultraviolet
(UV) B irradiation (Thyssen and Kezic 2014). Loss-of-function
mutations in filaggrin gene (FLG) define ichthyosis vulgaris,
and are strongly associated with atopic dermatitis (AD), a
chronic and relapsing inflammatory skin condition. Further
work showed that ~8–10% of normal Northern Europeans
are heterozygous carriers of common FLG mutations, while
only 1–4% of southern Europeans (i.e., Italy, France and
Greece) displayed these mutations, and only very rarely
could mutations be detected in African populations, i.e.,
Ethiopians, Moroccans, and South Africans (Cascella et al.
2011, 2015; Winge et al. 2011; Thyssen et al. 2013;
Thawer-Esmail et al. 2014). Although mutations were also
found in Asians, they were different from those encountered
in Northern Europeans (Irvine et al. 2011), where in particular
R501X and 2282del4 are common and affect ~2–4% of the
general population, as well as a substantial proportion of
northern Europeans with AD.
Based upon these published data and the observation
that mutation carriers had 10% increased serum vitamin
D concentrations compared with controls (Thyssen et al.
2012), we proposed that this latitude-dependent gradient
of FLG mutations across Europe, Asia and Africa could have
provided an evolutionary advantage for heterozygous FLG
mutation carriers, residing at northern latitudes (Thyssen
et al. 2014). Specifically, we hypothesized that depletion
of the FLG downstream product, t-UCA would facilitate the
intracutaneous synthesis of vitamin D3 by allowing in-
creased transcutaneous absorption of UVB photons. Such
loss-of-function FLG mutations would have provided an
evolutionary advantage for modern humans, living in the
far North of Europe, where little UV-B penetrates the
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atmosphere. Notably, many of these northerners eschewed
a marine seafood-based diet for cultural reasons.
Pertinently, in our perspective article, we noted that our
hypothesis was further supported by the significant corre-
lation between serum vitamin D levels in the general pop-
ulation and the prevalence of FLG mutations at different
latitudes (Thyssen et al. 2014).
In a recent article in this journal, Eaaswarkhanth et al.
(2016) challenged the UVB-Vitamin D3 Hypothesis. They
analyzed 2,504 human genomes, by interrogating publicly
available databases containing whole genome data to ge-
notype the copy number variation of filaggrin repeats
within FLG in 126 individuals from diverse ancestral back-
grounds. Based upon their data, these authors concluded
not only that the UVB-Vitamin D3 hypothesis is invalid, but
also that FLG genetic variations, including loss-of-function
variants, provide little or no impact on the fitness of modern
humans. While we welcome studies that reassess our hy-
pothesis, their conclusions are not valid. Specifically, the
allele frequency of R501X (rs 61816761) was 0.01 in
Northern Europeans in the 1000G database (supplemen-
tary table S1, Supplementary Material online), but is
known from detailed genotyping studies in several popula-
tions to actually be 0.02–0.04; they did not identify any
carriers of the 2282del4 (rs558269137) mutation, the
second most common mutation in northern Europeans
(Irvine et al. 2011). We find their analytical approach to
explain the frequencies of AD variants across multiple pop-
ulations interesting and the identification of many hereto-
fore unidentified mutations a very useful addition to the
FLG literature. An unbiased variant-calling approach has
indeed much to offer, but the existing detailed knowledge
of FLG architecture in Europeans provides a measure of
accuracy of genotying against which the G1000 data can
be compared. In this comparison the G1000 data (and ad-
ditional exome data) lack sensitivity. These discrepancies
may well be due to technical difficulties of NGS in accurate
annotation of a highly repetitive gene such as FLG. If the
European data are verifiably inaccurate (by a factor of 2- to
4-fold in some cases), it follows that allele frequencies in
other populations, where good verification data do not
exist, cannot be safely considered to be accurate either.
We believe these currently available genome data do not
allow sufficiently precise determination of the frequency of
FLG LoF mutations on which to base the authors’ elegant
evolutionary analyses. We cannot help but conclude that,
because the primary data are inaccurate, that this paper
neither proves nor disproves the FLG-Vitamin D3
Hypothesis, nor any other evolutionary theory, such as
the per cutaneous vaccination theory proposed by Irvine
and McLean (Brown and McLean 2012). It is unclear why
mutations in the gene encoding the human skin protein
hornerin should have been preserved for evolutionary or
adaptive purposes, but it is possible that other skin proteins
than filaggrin could have improved fitness.
Supplementary Material
Supplementary data is available at Genome Biology and
Evolution online.
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